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Abstract
Background -: Obesity is related to obstructive sleep apnea-hypopnea syndrome (OSAHS), but
its roles in OSAHS as cause or consequence are not fully clarified. Isocapnic intermittent hypoxia
(IIH) is a model of OSAHS. We verified the effect of IIH on body weight and brown adipose tissue
(BAT) of Wistar rats.
Methods:  Nine-month-old male breeders Wistar rats of two groups were studied: 8 rats
submitted to IIH and 5 control rats submitted to sham IIH. The rats were weighed at the baseline
and at the end of three weeks, after being placed in the IIH apparatus seven days per week, eight
hours a day, in the lights on period, simulating an apnea index of 30/hour. After experimental
period, the animals were weighed and measured as well as the BAT, abdominal, perirenal, and
epididymal fat, the heart, and the gastrocnemius muscle.
Results: Body weight of the hypoxia group decreased 17 ± 7 grams, significantly different from the
variation observed in the control group (p = 0,001). The BAT was 15% lighter in the hypoxia group
and reached marginally the alpha error probability (p = 0.054).
Conclusion: Our preliminary results justify a larger study for a longer time in order to confirm
the effect of isocapnic intermittent hypoxia on body weight and BAT.
Introduction
Sleep apnea is a threatening aftermath of the obesity epi-
demics [1]. Obstructive apneas start with the occlusion of
the pharynx after sleep onset, progress during 10 to 40 sec-
onds with increasing asphyxia, and end with an arousal
[2]. The episodes can be repeated hundreds of times lead-
ing to consequences via sleep fragmentation and intermit-
tent hypoxia (IH). IH can trigger inflammation and the
release of free radicals [3,4]. Although the data are con-
flicting [5,6], hypoxia seems to be the main factor causing
leptin increase in obstructive sleep apnea-hypopnea syn-
drome (OSAHS) patients [7]; since leptin is an appetite-
suppressing and metabolism-enhancing protein hor-
mone, the expected effect of such finding would be weight
loss in OSAHS. Weight reduction is associated with
improvements in sleep apnea pointing towards an etio-
logic role of obesity [8,9]. Obesity may be dually associ-
ated to obstructive apneas, acting as a cause, by narrowing
the pharynx [10,11] and as a consequence of apnea-
related sleep deprivation [12,13].
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The brown adipose tissue (BAT) [14] is an organ with the
specialized function of nonshivering thermogenesis,
through intracellular fat oxidation. Recently, it was
described that a significant percentage of adult human
population display activity compatible with the existence
of brown adipose tissue potentially significant for meta-
bolic physiology [15]. The uncoupling protein 1 (UCP1)
existent in BAT cells makes possible for the mitochondria
to release energy directly in heat form [16]. The metabolic
activity necessary for the muscles to produce the same
heat would require larger blood flow and oxygen con-
sumption rate. The UCP1 expression is regulated by cate-
cholamines, thyroid hormones and leptin and occurs, for
example, during the exposure to cold [17], in the postna-
tal period, in febrile stages or during hibernation [18].
Hypoxia induces body temperature reduction in mam-
mals mediated by the central nervous system, bringing
about decrease of oxygen consumption and increase of
hemoglobin-oxygen affinity. This adaptation may affect
the BAT activity. In rats, this body temperature decrease
could be mediated by the inhibition of cutaneous vaso-
constriction or of nonshivering thermogenesis [19]. The
metabolism and heat production in BAT are primarily
controlled by sympathetic impulses [20] and, during non-
shivering thermogenesis, more than a half of all the oxy-
gen captured is consumed by BAT [18].
Hypoxia stimulates the carotid body arterial chemorecep-
tors, whose fibers found in the carotid sinus activate neu-
rons of the solitary tract nucleus, enabling the
hypothalamus to control temperature through the auto-
nomic nervous system. Activation of the afferent arterial
chemoreceptors during brief hypoxia episodes increases
the sympathetic outflow [21].
Models of intermittent hypoxia are used in animals and in
cell cultures to demonstrate anatomic and functional
alterations, in sympathetic reactivity to hypoxia and
hipercapnia [22,23]. Studies that submit animals to short
cycles, alternating hypoxia and normoxia, preferably
maintaining isocapnic condition, at every 30 to 90 sec-
onds, during sleep, between 7 and 8 daily hours are exper-
imental models of sleep apnea. To the best of our
knowledge, no study using a model that simulates OSAHS
has investigated the effect of isocapnic intermittent
hypoxia (IIH) on the adipose tissue. Our study verified the
effect of IIH, simulating sleep apnea, on the adipose tissue
of adult Wistar rats.
Methods
Nine-month-old male breeders Wistar rats, recently
removed from breeding, were separated in two groups: 8
rats submitted to 21 days of IIH and 5 control rats, sub-
mitted to 21 days of sham IIH, both groups housed under
22°–24°C and ad libitum fed. The protocol was approved
by the local Ethics Committee. The rats were weighed at
the baseline and at the end of 21 days, after anesthesia,
prior to sacrifice. The nose-anus length was measured with
a ruler and rounded to the next centimeter. The Lee index
was calculated as the division of the body weight cubic
root in grams, by the nose-anus length in millimeters,
multiplied by 10 [24].
During three weeks, 7 days per week, for 8 hours a day,
from 9 a.m. to 5 p.m., in the lights on period, the rat cages
were covered with transparent acrylic lids connected to
the IIH system. Food and water supplies were kept
unchanged during the experimental procedure. A timer
activated a solenoid valve to release a mixture with 92%
of nitrogen and 8% of CO2 in the hypoxia chamber, for 60
seconds. At the end of this time interval, the nitrogen flow
in the cages had reduced the oxygen fraction from 21% to
approximately 7 ± 1% and increased the CO2 fraction to
approximately 5 ± 1%, lasting the nadir 12 ± 3 seconds. At
the end of the hypoxia cycle, the timer activated a fan for
60 seconds insufflating room air into the chamber, restor-
ing the oxygen fraction to 21%, in 30 ± 5 seconds, and
conducting the chamber air out of the room. In 120 sec-
onds, there was a full hypoxia/normoxia cycle; in 8 hours,
240 IIH periods occurred, the equivalent to an apnea
index of 30 per hour, a figure commonly observed in
patients with severe OSAHS.
In order to confirm the arterial blood oxygen saturation
(SaO2) level reached in the animals submitted to this
equipment, two anesthetized rats had the SaO2 measured
through a pulse oximeter for veterinary use (NONIN Med-
ical, Inc., Plymouth, Minnesota, USA). Repeated arterial
saturation falls were verified to values around 70%, SaO2
level usually observed in patients with severe OSAHS.
The sham IIH group remained in an adjacent cage and
underwent the same handling as the IIH group, but the
normoxia chamber was insufflated with air instead of N2
+ CO2. The purpose was to control for the stress arising
from cover installation on cages and from fan and gas
release noises. After three weeks, eight animals from the
IIH group and five from the sham IIH were anesthetized
for organs removal. Wet weight of white AT (abdominal
and epididymal), heart, and gastrocnemius muscle was
measured. The BAT was removed and weighed immedi-
ately after that in the two groups. Body composition was
determined by evaluating the fat mass, represented by the
weight in grams of the abdominal adipose white tissue
(epididymal, perirenal and mesenteric) and the interes-
capular BAT and the lean mass, represented by the sum of
the weight in grams of the gastrocnemius skeletal muscle
and the cardiac muscle, all of them removed and weighed
immediately after sacrificing the animals (Figure 1).Lipids in Health and Disease 2008, 7:26 http://www.lipidworld.com/content/7/1/26
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Statistical Analysis
Results are expressed as mean ± SD. To compare paired
observations of weights before and after 21 days we used
Willcoxon exact test. To compare IIH versus sham IIH we
employed Mann-Whitney's U with Fisher's exact one-
tailed test.
Results
As shown in Table 1, the average body weight of the ani-
mals from the IIH group decreased after 21 days, while it
did not change in the sham IIH group. We did not find
difference in heart dimensions. The weight loss and the
reduction in the Lee index in the IIH group were signifi-
cantly different from the variation observed in the sham
IIH group (p = 0,001). The BAT was lighter in the IIH
group and marginally reached the alpha error probability
(p = 0.05) (Table 1).
Discussion
The results of the present study suggest that 30 IIH cycles
per hour, 8 hours a day, during 21 days cause a reduction
in body weight and brown adipose tissue of Wistar mid-
dle-age retired breeder rats. The finding of body mass loss
and BAT reduction in rats submitted to IIH is original.
Diagram of the hypoxic and normoxic chambers Figure 1
Diagram of the hypoxic and normoxic chambers. Solenoid valve (SV).
Table 1: Mean and standard deviations of body weight, Lee Index and body fat distribution in the two groups of animals prior and after 






Initial body weight 446.75 ± 50.31 448.40 ± 62.67 0.362*
Final body weight 429.50 ± 52.88 451.60 ± 60.71 0.262*
Initial – final weight 17.25 ± 6.69 -3.20 ± 8.17 0.001**
Nasal – anal length 23.8 ± 0.8 23.4 ± 0.9 0.267*
Initial Lee index 0.320 ± 0.014 0.326 ± 0.015 0.111*
Final Lee index 0.315 ± 0.013 0.327 ± 0.014 0.015*
Initial-final Lee index 0.00428 ± 0.00187 -0.00079 ± 0.00188 0.001**
Gastrocnemius 1.04 ± 0.27 1.07 ± 0.17 0.308*
Heart 1.23 ± 0.137 1.24 ± 0.132 0.472*
Brown adipose tissue 0.51 ± 0.079 0.6 ± 0.075 0.054*
Epididymal fat 8.44 ± 2.558 9.65 ± 3.807 0.311*
Abdominal fat 19.58 ± 8.247 24.08 ± 16.048 0.528*
**Mann-Whitney; exact one-tailed test; * Willcoxon test.Lipids in Health and Disease 2008, 7:26 http://www.lipidworld.com/content/7/1/26
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Despite the reduced number of cases, the BAT difference
almost reaches statistic significance. Prior to reaching any
definitive conclusions, this study should be repeated in a
larger number of animals exposed to intermittent hypoxia
for longer periods.
Before engaging in the present study, we performed a pilot
study to collect evidence of an effect of IH on BAT. We
measured the wet weight of BAT of mice being eutha-
nasied after five weeks in IIH for another research proto-
col (unpublished data) to serve as a pilot. We found in 8
controls an average BAT wet weight of 0.0655 ± 0.005 g
and in the 16 mice of the IIH group an average of 0.0334
± 0.001 g, approximately half of the control group value
(p < 0.0001). Because mice have a low total weight and
minuscule BAT, we were concerned about errors occurring
during dissection of BAT and decided to do this protocol
with rats that are substantially larger. Speculating on what
could account for a more prominent effect of IH in the
mouse model (50% reduction) than in the rat (15%
reduction), two possibilities are of interest: first, mice
were submitted to 35 days of IIH against 21 days of the
rats; second, the easier dissection of the BAT in rats made
the results more exact. The latter is less likely since the var-
iation coefficient is less important in the mice. Our initial
experiences suggest that future research concentrate on
species differences and on the effects of IIH duration on
BAT.
The noradrenergic stimulus caused by IIH is the possible
determinant of BAT consumption, considering that IIH
raises the serum levels of sympathetic neurotransmitters
[25]. Interescapular BAT in the rat is densely innervated by
the sympathetic nervous system for the control of the tem-
perature in cold [26] and diet-induced thermogenesis.
Nonshivering thermogenesis performed by BAT is stimu-
lated by hypoxia [27]. In acute hypoxic conditions, the O2
consumption response in cold is reduced or thoroughly
suppressed by the shivering or nonshivering thermogene-
sis hypoxic depression. The BAT activity hypoxic depres-
sion mechanisms are not elucidated, although it is known
that, even in young animals, the thermogenesis inhibition
does not result from oxygen limitation, but from the
response regulated by hypoxia [28].
Wet weight is a more relevant physiological parameter for
white adipose tissue than for BAT. BAT wet weight may
decrease both in face of increased and decreased tissue
activity. To elucidate what causes the decrease in BAT it
will be necessary to measure the amount of UCP1 or at
least the protein amount in the BAT in future experiments.
Sleep was not recorded in this experiment; therefore, it is
difficult to ascertain that the animals were sleep deprived.
The overall effect of sleep fragmentation on total sleep
time of OSAHS patients is still obscure. In a IH study by
Veasey et al., in which sleep was recorded, mice increased
sleep time significantly, indicating sleepiness; while the
group submitted to two weeks of sham IH slept around
680 minutes per day, the IH group slept 900 minutes [29].
For the sake of reasoning, assuming that sleep time
increased, the probability that leptin was increased is min-
imal. It is necessary, therefore, that leptin levels are meas-
ured to control for this confounding factor and to
elucidate the effect of sleep fragmentation on leptin pro-
duction.
We chose 9-month old retired breeder male rats as sub-
jects in our protocol because these animals better simulate
the middle-aged, sexually active men who suffer from
OSAHS. There is some evidence that breeder male rats
show responses to oxidative stress that are different from
males that did not engage in reproductive activity [30].
Obesity is closely related to OSAHS, but until the present
moment, obesity roles in OSAHS are not fully clarified: as
predisponent factor, as consequence, or as both. If this
study's findings are confirmed, the significant weight loss
observed in the IIH group may be mediated by leptin
increase and is in keeping with findings of correlation
between hypoxia and leptin levels [7]. One interesting
model to further the understanding of the effect of IIH on
leptin is under way in our laboratory, repeating this exper-
iment in leptin knockout obese mice.
This is the first report of weight loss and reduction of BAT
under intermittent hypoxia. This line of research is war-
ranted since the findings raised numerous questions that
may be of relevance for sleep apnea patients. We recog-
nized the need of additional studies in different species
with larger number of animals and with longer exposi-
tions in order to confirm the effect of isocapnic intermit-
tent hypoxia on body weight and BAT.
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